RecruitingNot ApplicableNCT06576323

An Intervention Mapping Approach to Closing the Gap in Maternal OUD and Infant NAS Care (SUPPORT)

An Intervention Mapping Approach to Closing the Gap in Maternal OUD and Infant NAS Care

Sponsor

University of Pennsylvania

Enrollment

50 participants

Start Date

Jul 1, 2024

Study Type

INTERVENTIONAL

Conditions

Opioid-use Disorder Neonatal Abstinence Syndrome

Summary

The purpose of this study is to address the gap in maternal OUD treatment and infant neonatal opioid withdrawal syndrome care. The research team will develop a treatment model and a set of strategies to provide evidence-based OUD treatment to postpartum mothers in NICUs. First, the investigators will conduct a needs assessment via in-depth qualitative interviews with NICU mothers and clinicians. Then, with the expertise of the advisory board, the the researchers will create a protocol for implementing maternal OUD treatment at the NICU bedside. The researchers will then implement the protocol in two partner NICUs and evaluate the acceptability and feasibility to patients, providers, and clinical, and administrative leaders. The goal of this research study is to integrate maternal mental health and substance abuse treatment in pediatric settings and to refine, test, and examine the acceptability and feasibility of applying the adapted model.

Eligibility

Min Age: 18 Years

Inclusion Criteria10

Participants should be healthcare providers working within UPHS, who generally treat perinatal women or any individuals with OUD; for the purposes of this study, provider refers to a Medical Doctor (MD) or Doctor of Osteopathy (DO), Advanced Practice Practitioner, Nurse, or Social Worker.
Participants should provide direct care to NICU patients and/or their mothers
Participants should be proficient in English language
Participants should have access to a computer with internet connectivity or phone
Participants should be biological mothers of children hospitalized in the UPHS NICU for NAS
Participants should be diagnosed with opioid use disorder
We will use this same criteria to recruit new participants for Aim 3 if the same stakeholder interviewees are unavailable at the time of Aim 3.
Participants should be biological mothers of a child hospitalized in either of the two UPHS NICU for NAS (either HUP or PAH)
Participants should be no more than 4 weeks postpartum
Participants should have an Opioid Use Disorder than is currently untreated with medication assisted treatment or buprenorphine

Exclusion Criteria4

\- None
\- None
\- None
\- Active suicidal ideation, or other severe psychopathology that must be addressed before effective MOUD can be prescribed

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALAn implementation model for co-located Medications for Opioid Use Disorder (MOUD) prescription in the NICU

We will use implementation mapping to develop a suite of implementation strategies to deliver evidence-based MOUD prescription to mothers attending the bedside of their infants hospitalized in the NICU. The intervention itself is buprenorphine induction and treatment, however the model for delivery is not yet developed, consistent with the need for results from Aim 1 to inform the approach used to develop the implementation model in Aim 2.